InterVenn

InterVenn

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.intervenn.com

Last Round

Series C

Aug 2, 2021

Total Funding Raised

$244.4M

Momentum Score

50 /100

Company Overview

InterVenn is a biotechnology company that offers a biomarker and target discovery platform aimed at enhancing the early detection and triaging of ovarian and other cancers through the identification and analysis of glycoproteomic and PTM signals in human blood and tissue.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Drug Discovery, Precision Medicine, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

glycoproteomicsliquid biopsybiomarker discoverymass spectrometrymass specAI diagnosticsglycoprotein analysispatient stratificationcancer detectiondrug development toolslaboratory-developed testLDTovarian cancer diagnosticnon-invasive diagnosticsclinical trial supportprecision medicineproteomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InterVenn Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

InterVenn Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CAug 2, 2021
Series BNov 16, 2020
Series ADec 12, 2018

Key People

Founding team and executive leadership

Peter S.

Chief Financial Officer

Executive Team

InterVenn Investors

Notable investors and investment history

InvestorRounds
Xeraya CapitalSeries B, Series C
Ojjeh FamilySeries B
Highside Capital ManagementSeries C
Prado SVSeries A
SoftBank GroupSeries C
Genoa VenturesSeries B, Series C, Series A
Irving InvestorsSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 18, 2025

    Andrew Quong appointed as the new Chief Executive Officer.

InterVenn Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

InterVenn Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about InterVenn's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range44
Year Founded2017
Last FundingAug 2, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.